A simple liquid can stop cavities without drilling, major study confirms — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- JAMA Pediatrics published a Phase III trial of 830 children younger than 6, recruited through dental clinics, pediatric medical practices and Head Start programs in Michigan, New York and Iowa.
- Advantage Arrest 38% SDF stopped decay in more than half of the affected baby teeth when treatment was provided at six-month intervals.
- National Institute of Dental and Craniofacial Research provided more than $12 million for the four-university trial, while Elevate Oral Care supplied the tested formulation.
- Margherita Fontana called SDF effective and safe for children as young as 1; it can be painted on in seconds without drilling, injections or sedation, but permanently darkens decay and does not replace lost tooth structure.
- FDA approved SDF as a medical device for tooth sensitivity in 2014, while U.S. cavity treatment has remained off-label; the trial provides evidence for a drug application covering cavity use.
- Amr Moursi said removing SDF's off-label status would encourage greater provider use, enhanced payments by insurers and more consistent product quality.
Why it matters: For the more than 40% of U.S. children affected by cavities, trial data showing 38% SDF arrests decay in over half of treated baby teeth offers a less painful option than drilling. Researchers say FDA drug approval would end off-label cavity use and encourage provider use, insurer reimbursement and more consistent product quality.
Ask SkimNews
